SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-000773
Filing Date
2014-05-06
Accepted
2014-05-06 10:50:16
Documents
6
Period of Report
2013-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 12270
2 PRESS RELEASE DATED OCTOBER 15, 2013 ex991.htm EX-99.1 82420
3 Q1 INTERIM FINANCIAL STATEMENTS ex992.htm EX-99.2 228363
4 Q1 MANAGEMENTS DISCUSSION AND ANALYSIS ex993.htm EX-99.3 136723
5 CEO/CFO CERTIFICATES ex994.htm EX-99.4 18171
6 LOGO logo.jpg GRAPHIC 3211
  Complete submission text file 0001279569-14-000773.txt   483785
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14815767
SIC: 2836 Biological Products, (No Diagnostic Substances)